Evidence map›Paper›PMID 42020813›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Clinical research analysis of [

Hongyu Yang, Meiling Hu, Bingyan Shen, Ya Liu, Lin Liu, Yu Zhang, Yue Chen

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongyu YangDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China.
Meiling HuDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China.
Bingyan ShenDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China.
Ya LiuDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China.
Lin LiuDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China.
Yu ZhangDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China. zhangyu309@126.com.
Yue ChenDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, No 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China. chenyue5523@126.com.ORCID http://orcid.org/0000-0003-4088-7649

Funding

Gansu Provincial Science and Technology Major Project 23ZDFA014National Key Research and Development Program (NKRDP) Project 2024YFC2419405Sichuan Provincial Department of Science and Technology 2024YFCY0005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

[225Ac]Ac-DOTATATENeuroendocrine neoplasmsPeptide receptor radionuclide therapySomatostatin receptor

Identifiers

PMID42020813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.